Flossbach Von Storch AG increased its holdings in AMETEK, Inc. (NYSE:AME) by 12.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,605 shares of the technology company’s stock after acquiring an additional 6,000 shares during the quarter. Flossbach Von Storch AG’s holdings in AMETEK were worth $4,241,000 at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Point72 Asset Management L.P. increased its holdings in shares of AMETEK by 67.6% in the 2nd quarter. Point72 Asset Management L.P. now owns 125,700 shares of the technology company’s stock valued at $9,071,000 after acquiring an additional 50,700 shares during the period. Teacher Retirement System of Texas increased its holdings in shares of AMETEK by 9.9% in the 2nd quarter. Teacher Retirement System of Texas now owns 229,597 shares of the technology company’s stock valued at $16,568,000 after acquiring an additional 20,642 shares during the period. Dynamic Technology Lab Private Ltd increased its holdings in shares of AMETEK by 92.6% in the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 18,202 shares of the technology company’s stock valued at $1,313,000 after acquiring an additional 8,749 shares during the period. Global X Management Co LLC increased its holdings in shares of AMETEK by 23.2% in the 2nd quarter. Global X Management Co LLC now owns 7,584 shares of the technology company’s stock valued at $547,000 after acquiring an additional 1,426 shares during the period. Finally, Verition Fund Management LLC increased its holdings in shares of AMETEK by 208.1% in the 2nd quarter. Verition Fund Management LLC now owns 25,291 shares of the technology company’s stock valued at $1,825,000 after acquiring an additional 17,082 shares during the period. 85.09% of the stock is currently owned by institutional investors and hedge funds.
Shares of AME opened at $74.64 on Wednesday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.42 and a current ratio of 2.06. The firm has a market capitalization of $16.84 billion, a price-to-earnings ratio of 28.60, a PEG ratio of 2.03 and a beta of 1.30. AMETEK, Inc. has a 1 year low of $64.91 and a 1 year high of $81.92.
AMETEK (NYSE:AME) last announced its quarterly earnings data on Thursday, November 1st. The technology company reported $0.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.04. The company had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.18 billion. AMETEK had a net margin of 17.06% and a return on equity of 17.08%. AMETEK’s revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.66 EPS. As a group, equities research analysts expect that AMETEK, Inc. will post 3.27 EPS for the current year.
In other news, Director Elizebeth R. Varet sold 1,500 shares of the company’s stock in a transaction on Friday, September 7th. The shares were sold at an average price of $78.10, for a total transaction of $117,150.00. Following the transaction, the director now directly owns 4,148 shares of the company’s stock, valued at approximately $323,958.80. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Elizebeth R. Varet sold 3,000 shares of the company’s stock in a transaction on Wednesday, August 29th. The stock was sold at an average price of $77.26, for a total transaction of $231,780.00. Following the transaction, the director now directly owns 104,810 shares in the company, valued at $8,097,620.60. The disclosure for this sale can be found here. Insiders sold a total of 56,925 shares of company stock worth $4,580,360 over the last three months. 2.00% of the stock is currently owned by corporate insiders.
A number of brokerages have recently commented on AME. ValuEngine raised shares of AMETEK from a “hold” rating to a “buy” rating in a report on Tuesday. Morgan Stanley cut their target price on shares of AMETEK from $84.00 to $81.00 and set an “equal weight” rating on the stock in a report on Monday. Robert W. Baird lifted their target price on shares of AMETEK from $82.00 to $84.00 and gave the company an “outperform” rating in a report on Friday, November 2nd. BMO Capital Markets dropped their price objective on shares of AMETEK from $93.00 to $91.00 and set an “outperform” rating on the stock in a research note on Friday, November 2nd. Finally, Cowen reissued a “buy” rating and issued a $85.00 price objective on shares of AMETEK in a research note on Sunday, August 12th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. AMETEK has a consensus rating of “Buy” and a consensus target price of $87.00.
WARNING: This piece was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/11/07/flossbach-von-storch-ag-acquires-6000-shares-of-ametek-inc-ame.html.
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. Its Electronic Instruments Group segment offers advanced instruments for the process, power and industrial, and aerospace markets; process and analytical instruments for the oil, gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage markets; and instruments for the laboratory equipment, ultraprecision manufacturing, medical, and test and measurement markets.
Featured Story: Price to Earnings Ratio (PE)
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.